EP Patent

EP4159741A1 — Method for producing a chimeric polynucleotide encoding a polypeptide having a triazole-containing internucleotide linkage

Assigned to ModernaTx Inc · Expires 2023-04-05 · 3y expired

What this patent protects

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of chimeric polynucleotide molecules.

USPTO Abstract

The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of chimeric polynucleotide molecules.

Drugs covered by this patent

Patent Metadata

Patent number
EP4159741A1
Jurisdiction
EP
Classification
—
Expires
2023-04-05
Drug substance claim
No
Drug product claim
No
Assignee
ModernaTx Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.